Angel One recommends Buy on Lincoln Pharmaceuticals Ltd with a Target Price of Rs. 845 per share, potential upside 39%
New Delhi [India], August 31 –Leading Broking and Research company, Angel One has come out with a research report on Ahmedabad based pharmaceutical company, Lincoln Pharmaceuticals Ltd (BSE: 531633 | NSE: LINCOLN). One of India’s leading healthcare companies, Lincoln Pharmaceuticals Ltd has reported excellent operational and financial performance for Q1 FY27 ended June 30, 2026. The […]
Continue Reading